Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Exploring the Potential of Cefepime-Enmetazobactam Against Carbapenem-Resistant Gram-Negative Bacteria

    Antimicrobial resistance remains one of the biggest threats to global health. A recent study published in Clinical Microbiology and Infection evaluates the in vitro activity of cefepime-enmetazobactam, a novel β-lactam/β-lactamase inhibitor combination, against carbapenem-resistant Gram-negative pathogens.

    2025.02.04
  • Rethinking Antibiotic Strategies: The Oral vs. IV Debate in Severe Infections

    In the world of inpatient infectious disease (ID) consults, a recurring challenge surfaces: the hesitation to shift from IV to oral antibiotics, even when clinical evidence supports it. This dialogue between an ID consultant and a surgeon, as shared by Dr. Paul Sax in NEJM Journal Watch, perfectly illustrates the tension.

    2025.02.04
  • Impact of Pneumosil Mass Campaigns on Reducing Pneumococcal Carriage in Niger: Promising Results from a Cluster-Randomised Trial

    Valuable researchers have conducted a groundbreaking three-arm, open-label, cluster-randomised trial in Niger to evaluate the effectiveness of mass campaigns using full and fractional doses of the pneumococcal conjugate vaccine (Pneumosil, PCV10) in reducing nasopharyngeal pneumococcal carriage among children aged 1–9 years.

    2025.02.04
  • A New Hope in Preventing Clostridioides difficile Infections: The Power of a Naturally Avirulent Strain

    Valuable researchers have uncovered promising insights into combating Clostridioides difficile infection (CDI), a leading cause of healthcare-associated infections. The study reveals that a naturally avirulent C. difficile strain, ST1-75, can protect against CDI by outcompeting virulent strains such as R20291.

    2025.02.04
  • Exploring Effective Treatments for Invasive Candidiasis: Insights from Recent Research

    A recent analysis sheds light on the clinical and mycological outcomes of treating candidaemia and invasive candidiasis with rezafungin compared to caspofungin. This study, pooling data from the STRIVE and ReSTORE trials, evaluated the efficacy of once-weekly rezafungin versus daily caspofungin across various Candida species. The findings suggest that rezafungin offers comparable, and in some…

    2025.02.04
  • Exploring Procalcitonin-Guided Antibiotic Therapy in Pediatric Infections: Insights from the BATCH Trial

    A recent pragmatic, multicenter randomized controlled trial (BATCH) conducted across 15 hospitals in the UK has provided critical insights into the effectiveness of procalcitonin-guided algorithms in managing antibiotic treatment for children hospitalized with confirmed or suspected bacterial infections.

    2025.02.04
  • Dysregulated Neutrophil Function in Hospitalized Older Adults with Pneumonia and Sepsis: A New Insight

    A recent study by valuable researchers sheds light on the complex immune response in older adults hospitalized with community-acquired pneumonia (CAP) and sepsis. Their research reveals that although these patients exhibit impaired neutrophil functions, such as reduced migratory accuracy and respiratory burst, their glycolytic metabolism remains preserved. This finding challenges the assumption that metabolic dysfunction…

    2025.02.04
  • Uncovering a New Pathway in Crohn’s Disease: How Intestinal E. coli-Produced Yersiniabactin Drives Fibrosis

    A groundbreaking study by Ju-Hyun Ahn and colleagues sheds new light on the role of the gut microbiota in promoting intestinal fibrosis in Crohn’s disease. The research reveals that adherent-invasive Escherichia coli (AIEC), which produce the metallophore yersiniabactin (Ybt), play a critical role in triggering profibrotic responses in the inflamed intestine.

    2025.02.04
«previous next»
Recent Posts
  • 2026 Xianghu Breast Cancer Treatment Frontiers Conference | Professor Zhanhong Chen: Cardio-Oncology Supports Comprehensive Breast Cancer Care, While ADCs Reshape Treatment for Advanced HER2-Positive Disease
  • 2026 Xianghu Breast Cancer Treatment Frontiers Conference | Professor Hai Hu: Advancing Precision Medicine and Exploring New Approaches to Breast Cancer Care
  • 2026 Xianghu Breast Cancer Treatment Frontiers Conference | Professor Xiaojia Wang: Integrating Guideline Outreach with Academic Forums to Advance Standardized and Equitable Breast Cancer Care
  • 2026 East China Breast Cancer Salon | Professor Michael Gnant: Neoadjuvant Therapy Is Reshaping Breast Surgery, While China-Europe Collaboration Opens New Pathways in Care
  • 2026 East China Breast Cancer Salon | Professor Zefei Jiang: Strengthening Regional Academic Exchange to Foster the Growth of Chinese Oncology Research
Recent Comments
    Archives
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top